News | Treatment Planning | October 31, 2018

Mirada Medical Showcases DLCExpert AI-Based Radiotherapy Contouring Software at ASTRO 2018

Artificial intelligence software brings quality and consistency to the task of contouring critical structures for radiation treatment planning

Mirada Medical Showcases DLCExpert AI-Based Radiotherapy Contouring Software at ASTRO 2018

October 31, 2018 — Medical imaging software company Mirada Medical showcased its DLCExpert at the recent American Society for Radiation Oncology (ASTRO) 2018 annual meeting, oct. 21-24 in San Antonio, Texas. The product, which has received U.S. Food and Drug Administration (FDA) 510(k) clearance, is the world’s first artificial intelligence (AI)-powered autocontouring solution. The software is already in use in multiple academic medical centers worldwide.

DLCExpert automatically generates contours that users often find indistinguishable from those drawn by clinical experts, according to Mirada Medical. The software has been shown to bring quality and consistency to the task of contouring critical structures for radiation treatment planning.

DLCExpert received CE Marking for the European market earlier this year. Medical institutions across Europe are currently commissioning the product to exploit the significant benefits that AI brings to their contouring workflow.

Andre Dekker, professor of clinical data science, Department of Radiation Oncology at the Maastro Clinic in Maastricht, The Netherlands, stated, “The contours generated by DLCExpert are the closest to clinically acceptable contours we’ve seen from any autocontouring system we have evaluated. For some organs, our clinicians found it very hard to distinguish between their own contours and those that were automatically generated”.

U.S. regulatory clearance for DLCExpert was granted as part of the FDA 510(k) for Workflow Box 2.0, Mirada’s Zero-Click automation platform. DLCExpert is available as an option, along with five additional Zero-Click workflows, including multi-modal autocontouring, routing of data and support for the integration of custom applications.

See an example of this technology in the VIDEO: Artificial Intelligence Automatic Contouring and Segmentation For Radiotherapy.

For more information: www.mirada-medical.com

Related Content

News | Radiation Therapy | May 06, 2021
May 6, 2021 — Individuals living with severe...
The emergence of #therapeutic #radiopharmaceuticals and its adoption in #cancer care provide one more weapon in combating cancer

Getty Images

Feature | Radiation Oncology | May 04, 2021 | By Vinay Shivaprasad
The term nuclear medicine is associated with the diag
#prostatecancer During the first wave of the corona pandemic, 36 percent fewer men were diagnosed with prostate cancer in Sweden than in previous years.

Getty Images

News | Prostate Cancer | April 30, 2021
April 30, 2021 — During the first wave of the corona pandemic, 36 percent fewer men were diagnosed with prostate canc
A phase 1 clinical trial led by investigators at the University of Chicago Medicine testing the effects of stereotactic body radiotherapy for treating multiple metastases has determined that treatments used for single tumors can also be safely used for treating patients with multiple metastases.

Image courtesy of Accuray

News | Stereotactic Body Radiation Therapy (SBRT) | April 23, 2021
April 23, 2021 — A phase 1 clinical trial led by investigators at the...
A Norwegian study for the first time reveals benefit of the #PARP inhibitor #Olaparib in patients with early #breastcancer not harboring germline mutations

Getty Images

News | Radiation Therapy | April 22, 2021
April 22, 2021 — Targeted therapy in early stages of breas...
Varian announced it is collaborating with Google Cloud to build an advanced artificial intelligence (AI) based diagnostic platform to aid in the fight against cancer. Varian and Google Cloud AI embarked on a deployment journey, using Neural Architecture Search (NAS) technology via Google Cloud AI Platform, to create AI models for organ segmentation — a crucial and labor-intensive step in radiation oncology that can be a bottleneck in the cancer treatment clinical workflow.
News | Artificial Intelligence | April 08, 2021
April 8, 2021 — Varian announced it is collaborating with Google...
Brain tumors edged out by artificial intelligence: VBrain applies auto-contouring to the three most common types of brain tumors: brain metastasis, meningioma and acoustic neuroma.

Brain tumors edged out by artificial intelligence: VBrain applies auto-contouring to the three most common types of brain tumors: brain metastasis, meningioma and acoustic neuroma.

News | Artificial Intelligence | April 07, 2021
April 7, 2021 — Vysioneer, a leader in a...
The National Comprehensive Cancer Network® (NCCN®) and the American Cancer Society (ACS) are teaming up with leading health organizations across the country to endorse the safe resumption of cancer screening and treatment during the ongoing COVID-19 pandemic.
News | Radiation Therapy | March 31, 2021
March 31, 2021 — Doctors who oversee cancer clinics say that new patients are arriving for treatment with more advanc